在接受辅助生殖技术治疗的妇女中控制发作
Aisha A Abdulrazaq1, Alessandra J Ainsworth2, Jeffrey W Britton1
1Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Epilepsia
|August 19, 2023
概括
辅助生殖技术 (ART) 对于患有的妇女来说似乎是安全的,在生育治疗期间没有观察到发作频率的增加. 这表明ART可能不会对WWE的扣押控制产生负面影响.
科学领域:
- 神经学 神经学
- 生殖医学 生殖医学
- 妇女健康 妇女健康
背景情况:
- 会影响生育年龄的女性.
- 像辅助生殖技术 (ART) 这样的生育治疗引起了对控制的担忧.
研究的目的:
- 评估在接受ART的女性 (WWE) 中的控制.
- 为了确定ART是否会影响WWE的发作频率.
主要方法:
- 对12名接受ART治疗的患者妇女的回顾性图表审查.
- 在ART和怀孕之前和期间的发作频率的比较.
主要成果:
- 在ART期间,在患有的女性中没有观察到发作频率的增加.
- 在12名女性中,11名女性在整个生育治疗期间保持无发作.
- 怀孕和活产发生在大多数病例中.
结论:
- 在患有的女性中,ART可能不会对控制构成威胁.
- 需要进行更大规模的研究来证实这些初步发现.
相关概念视频
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Antiepileptic Drugs: Potassium Channel Activators
211
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
211
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
344
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
344
Seizures: Classification
411
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
411
Antiepileptic Drugs: GABAergic Pathway Potentiators
460
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
460


